Henry Schein Dental To Showcase The Company's Expansive Portfolio Of Solutions At Chicago Midwinter Dental Meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Henry Schein (HSIC) PT Lowered to $57 at UBS
February 25, 2019 7:11 AM ESTUBS analyst Kevin Caliendo lowered the price target on Henry Schein (NASDAQ: HSIC) to $57.00 (from $59.00) while maintaining a Sell rating.
... MoreHenry Schein (HSIC) PT Lowered to $65 at Stifel
February 21, 2019 9:11 AM ESTStifel analyst Jonathan Block lowered the price target on Henry Schein (NASDAQ: HSIC) to $65.00 (from $85.00) while maintaining a Hold rating following the company's 4Q. Results were lighter than expected. Adjusted internal sales growth of +2.6% was below +4.8% estimates, and the 4Q18 two-year stacked adjusted... More
Henry Schein (HSIC) PT Lowered to $59 at Baird
February 21, 2019 8:54 AM ESTBaird analyst Jeff Johnson lowered the price target on Henry Schein (NASDAQ: HSIC) to $59.00 (from $66.00) while maintaining a Neutral rating. Organic revenue growth of +3.1% finished above pre-call estimates of +2.4%. However, organic growth in two of HSIC's higher-margin segments finished below expectations, contributing... More

